BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37578543)

  • 1. Abdominal pain is associated with an increased risk of future healthcare resource utilization in inflammatory bowel disease.
    Zubrzycka I; Bogale K; Stuart A; Cesaire M; Walter V; Dalessio S; Tinsley A; Williams E; Clarke K; Coates MD
    Int J Colorectal Dis; 2023 Aug; 38(1):213. PubMed ID: 37578543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease.
    Bogale K; Maheshwari P; Kang M; Gorrepati VS; Dalessio S; Walter V; Stuart A; Koltun W; Bernasko N; Tinsley A; Williams ED; Clarke K; Coates MD
    Sci Rep; 2022 Jun; 12(1):10577. PubMed ID: 35732802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease.
    Gu P; Kapur A; Li D; Haritunians T; Vasiliauskas E; Shih DQ; Targan SR; Spiegel BM; Mcgovern DP; Black JT; Melmed GY
    J Dig Dis; 2018 Jan; 19(1):15-23. PubMed ID: 29251413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Tan MC; El-Serag HB; Hou JK
    Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort.
    Perler BK; Ungaro R; Baird G; Mallette M; Bright R; Shah S; Shapiro J; Sands BE
    BMC Gastroenterol; 2019 Apr; 19(1):47. PubMed ID: 30940072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal Pain After Pediatric Inflammatory Bowel Disease Diagnosis: Results From the ImproveCareNow Network.
    Murphy LK; Suskind DL; Qu P; Zhou C; Gashi K; Kawamura JS; Palermo TM;
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):749-754. PubMed ID: 32910089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes.
    Nene S; Gonczi L; Kurti Z; Morin I; Chavez K; Verdon C; Reinglas J; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
    World J Gastroenterol; 2020 Feb; 26(7):759-769. PubMed ID: 32116423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
    Kumar A; Shenoy V; Buckley MC; Durbin L; Mackey J; Mone A; Swaminath A
    Dig Dis Sci; 2022 Oct; 67(10):4851-4865. PubMed ID: 35624326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of a subsequent diagnosis of inflammatory bowel disease in subjects with ophthalmic disorders associated with inflammatory bowel disease: a retrospective cohort analysis of UK primary care data.
    King D; Chandan JS; Thomas T; Denniston AK; Braithwaite T; Niranthrankumar K; Reulen R; Adderley N; Trudgill NJ
    BMJ Open; 2022 May; 12(5):e052833. PubMed ID: 35545379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysubstance use in inflammatory bowel disease is associated with increased risk of emergency department visits: a longitudinal study.
    Bogale K; Zubrzycka I; Stuart A; Cesaire M; Walter V; Tinsley A; Williams E; Clarke K; Coates MD
    Ann Gastroenterol; 2023; 36(6):630-636. PubMed ID: 38023977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.
    Coates MD; Dalessio S; Walter V; Stuart A; Bernasko N; Tinsley A; Razeghi S; Williams ED; Clarke K; Vrana K
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):445-450. PubMed ID: 33998892
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients.
    Srinath AI; Goyal A; Zimmerman LA; Newara MC; Kirshner MA; McCarthy FN; Keljo D; Binion D; Bousvaros A; DeMaso DR; Youk A; Szigethy EM
    Inflamm Bowel Dis; 2014 Aug; 20(8):1329-40. PubMed ID: 24983975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Inflammatory Bowel Disease.
    Bouhuys M; Lexmond WS; van Rheenen PF
    Pediatrics; 2023 Jan; 151(1):. PubMed ID: 36545774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Biochemical Parameters, Healthcare Resource and Medication Use in the 5 Years Preceding IBD Diagnosis: A Health Maintenance Organization Cohort Study.
    Cohen NA; Kliper E; Zamstein N; Ziv-Baran T; Waterman M; Hodik G; Tov AB; Kariv R
    Dig Dis Sci; 2023 Feb; 68(2):414-422. PubMed ID: 36221010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease.
    Rodríguez-Lago I; Aguirre U; Ramírez de la Piscina P; Muñagorri A; Zapata E; Higuera R; Montalvo I; Iriarte A; Fernández-Calderón M; Arreba P; Carrascosa J; Cabriada JL; Barreiro-de Acosta M
    United European Gastroenterol J; 2023 Feb; 11(1):9-18. PubMed ID: 36547009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of dementia in patients with inflammatory bowel disease: a Danish population-based study.
    Rønnow Sand J; Troelsen FS; Horváth-Puhó E; Henderson VW; Sørensen HT; Erichsen R
    Aliment Pharmacol Ther; 2022 Sep; 56(5):831-843. PubMed ID: 35781292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
    Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
    Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.